Cargando…
Cost‐effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy‐resistant depression at secondary mental health care settings
AIM: Pharmacotherapy is the primary treatment strategy in major depression. However, two‐thirds of patients remain depressed after the initial antidepressant treatment. Augmented cognitive behavioral therapy (CBT) for pharmacotherapy‐resistant depression in primary mental health care settings proved...
Autores principales: | Sado, Mitsuhiro, Koreki, Akihiro, Ninomiya, Akira, Kurata, Chika, Mitsuda, Dai, Sato, Yasunori, Kikuchi, Toshiaki, Fujisawa, Daisuke, Ono, Yutaka, Mimura, Masaru, Nakagawa, Atsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293226/ https://www.ncbi.nlm.nih.gov/pubmed/34459077 http://dx.doi.org/10.1111/pcn.13298 |
Ejemplares similares
-
Effectiveness of cognitive behavioural therapy augmentation in major depression treatment (ECAM study): study protocol for a randomised clinical trial
por: Nakagawa, Atsuo, et al.
Publicado: (2014) -
Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial
por: Sado, Mitsuhiro, et al.
Publicado: (2022) -
Formulation of a Mapping Formula to Estimate Well-Being Utility from Clinical Subjective Well-Being Scales
por: Koreki, Akihiro, et al.
Publicado: (2022) -
Effectiveness and Cost-effectiveness of Online Brief Mindfulness-based Cognitive Therapy for the Improvement of Productivity in the Workplace: Study Protocol for a Randomized Controlled Trial
por: Sado, Mitsuhiro, et al.
Publicado: (2022) -
Economic Evaluation Alongside a Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Healthy Adults
por: Nagaoka, Maki, et al.
Publicado: (2023)